| The GPR55 ligand L‐α‐lysophosphatidylinositol promotes RhoA‐dependent Ca2+ signaling and NFAT activation CM Henstridge, NAB Balenga, LA Ford, RA Ross, M Waldhoer, AJ Irving The FASEB Journal 23 (1), 183-193, 2009 | 377 | 2009 |
| Beyond the neuron–cellular interactions early in Alzheimer disease pathogenesis CM Henstridge, BT Hyman, TL Spires-Jones Nature Reviews Neuroscience 20 (2), 94-108, 2019 | 366 | 2019 |
| Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome KM Jung, M Sepers, CM Henstridge, O Lassalle, D Neuhofer, H Martin, ... Nature communications 3 (1), 1080, 2012 | 331 | 2012 |
| Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling B Dudok, L Barna, M Ledri, SI Szabó, E Szabadits, B Pintér, ... Nature neuroscience 18 (1), 75-86, 2015 | 300 | 2015 |
| GPR55 ligands promote receptor coupling to multiple signalling pathways CM Henstridge, NAB Balenga, R Schröder, JK Kargl, W Platzer, L Martini, ... British journal of pharmacology 160 (3), 604-614, 2010 | 278 | 2010 |
| TDP-43 depletion in microglia promotes amyloid clearance but also induces synapse loss RC Paolicelli, A Jawaid, CM Henstridge, A Valeri, M Merlini, JL Robinson, ... Neuron 95 (2), 297-308. e6, 2017 | 243 | 2017 |
| Synaptic pathology: a shared mechanism in neurological disease CM Henstridge, E Pickett, TL Spires-Jones Ageing research reviews 28, 72-84, 2016 | 209 | 2016 |
| Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55 CM Henstridge, NAB Balenga, J Kargl, C Andradas, AJ Brown, A Irving, ... Molecular endocrinology 25 (11), 1835-1848, 2011 | 202 | 2011 |
| Amyloid beta and tau cooperate to cause reversible behavioral and transcriptional deficits in a model of Alzheimer’s disease EK Pickett, AG Herrmann, J McQueen, K Abt, O Dando, J Tulloch, P Jain, ... Cell reports 29 (11), 3592-3604. e5, 2019 | 198 | 2019 |
| Multiple forms of endocannabinoid and endovanilloid signaling regulate the tonic control of GABA release SH Lee, M Ledri, B Tóth, I Marchionni, CM Henstridge, B Dudok, L Barna, ... Journal of Neuroscience 35 (27), 10039-10057, 2015 | 161 | 2015 |
| Glial contribution to excitatory and inhibitory synapse loss in neurodegeneration CM Henstridge, M Tzioras, RC Paolicelli Frontiers in cellular neuroscience 13, 63, 2019 | 153 | 2019 |
| Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis CM Henstridge, DI Sideris, E Carroll, S Rotariu, S Salomonsson, ... Acta neuropathologica 135 (2), 213-226, 2018 | 153 | 2018 |
| Synaptic phosphorylated α-synuclein in dementia with Lewy bodies M Colom-Cadena, J Pegueroles, AG Herrmann, CM Henstridge, L Munoz, ... Brain 140 (12), 3204-3214, 2017 | 140 | 2017 |
| Region-specific depletion of synaptic mitochondria in the brains of patients with Alzheimer’s disease EK Pickett, J Rose, C McCrory, CA McKenzie, D King, C Smith, ... Acta neuropathologica 136 (5), 747-757, 2018 | 133 | 2018 |
| An essential role for constitutive endocytosis, but not activity, in the axonal targeting of the CB1 cannabinoid receptor NA McDonald, CM Henstridge, CN Connolly, AJ Irving Molecular pharmacology 71 (4), 976-984, 2007 | 116 | 2007 |
| Comparative profiling of the synaptic proteome from Alzheimer’s disease patients with focus on the APOE genotype R Hesse, ML Hurtado, RJ Jackson, SL Eaton, AG Herrmann, ... Acta neuropathologica communications 7 (1), 214, 2019 | 111 | 2019 |
| Non-fibrillar oligomeric amyloid-β within synapses EK Pickett, RM Koffie, S Wegmann, CM Henstridge, AG Herrmann, ... Journal of Alzheimer’s Disease 53 (3), 787-800, 2016 | 105 | 2016 |
| Fluorescent ligand binding reveals heterogeneous distribution of adrenoceptors and ‘cannabinoid‐like’receptors in small arteries CJ Daly, RA Ross, J Whyte, CM Henstridge, AJ Irving, JC McGrath British journal of pharmacology 159 (4), 787-796, 2010 | 105 | 2010 |
| Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss MA White, Z Lin, E Kim, CM Henstridge, E Pena Altamira, CK Hunt, ... Acta neuropathologica communications 7 (1), 166, 2019 | 99 | 2019 |
| Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification NJ Izzo, CM Yuede, KM LaBarbera, CS Limegrover, C Rehak, R Yurko, ... Alzheimer's & Dementia 17 (8), 1365-1382, 2021 | 98 | 2021 |
Prof Tara Spires-Jones, DPhil(Oxon),...University of EdinburghVerified email at ed.ac.uk
